CRISPR/Cas9: Role of genome editing in cancer immunotherapy
S. Vimal(Saveetha University), Azhagu Madhavan Sivalingam(Saveetha University), Inamul Hasan Madar(Saveetha University), Lakshmi Thangavelu(Saveetha University), Logalakshmi Thirumani(Saveetha University)
Cited by 10
Related Papers
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
|Stem Cell Research & Therapy|2021|76
Potential of banana based cellulose materials for advanced applications: A review on properties and technical challenges
|Carbohydrate Polymer Technologies and Applications|2023|44
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models
|European Journal of Pharmacology|2022|36